USPH director receives 2,306-share stock grant

Gilmartin Kathleen A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Gilmartin Kathleen A reported acquisition or exercise transactions in this Form 4 filing.

U.S. Physical Therapy director Kathleen A. Gilmartin received an award of 2,306 shares of Common Stock, valued at $61.61 per share. This restricted stock grant increases her direct holdings to 27,092 shares. Restrictions lapse in stages through March 6, 2027, contingent on continued board service.

Insider Trade Summary

Grant/Award: 2,306 shares

Grant/Award 1 txn

Insider Gilmartin Kathleen A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,306	$61.61	$142K

Holdings After Transaction: Common Stock — 27,092 shares (Direct)

Footnotes (1)

1. F1. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates.

Key Figures

Restricted stock grant: 2,306 shares Grant price: $61.61 per share Post-transaction holdings: 27,092 shares +3 more

6 metrics

Restricted stock grant 2,306 shares Common Stock award to director on May 19, 2026

Grant price $61.61 per share Valuation of restricted stock award

Post-transaction holdings 27,092 shares Total Common Stock directly held after grant

First vesting tranche 1,153 shares Restrictions lapse on August 20, 2026

Second vesting tranche 576 shares Restrictions lapse on November 20, 2026

Third vesting tranche 577 shares Restrictions lapse on March 6, 2027

Key Terms

restricted stock, Amended and Restated 2003 Stock Incentive Plan, Common Stock, grant, award, or other acquisition

4 terms

restricted stock financial

"Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Amended and Restated 2003 Stock Incentive Plan financial

"Granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan."

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did USPH director Kathleen Gilmartin report?

Kathleen Gilmartin reported receiving 2,306 shares of USPH Common Stock as a restricted stock grant. The award was priced at $61.61 per share and represents equity compensation rather than an open-market purchase or sale.

How many USPH shares does Kathleen Gilmartin hold after this Form 4?

After the restricted stock grant, Kathleen Gilmartin directly holds 27,092 shares of U.S. Physical Therapy Common Stock. This total includes the newly granted 2,306 restricted shares that vest over time, assuming she remains a director on specified future dates.

When do Kathleen Gilmartin’s newly granted USPH restricted shares vest?

The 2,306 restricted USPH shares vest in three tranches: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, provided she continues serving as a director on those dates.

Was Kathleen Gilmartin’s USPH Form 4 a stock purchase or compensation grant?

The Form 4 reflects a compensation grant, not an open-market purchase. Kathleen Gilmartin acquired 2,306 USPH shares as restricted stock under a company stock incentive plan, categorized as a grant, award, or other acquisition rather than a traditional buy transaction.

Under which plan were Kathleen Gilmartin’s USPH restricted shares granted?

The restricted stock award of 2,306 USPH shares was granted under the Company Amended and Restated 2003 Stock Incentive Plan. This plan provides equity-based compensation, with vesting tied to conditions such as continued service on the company’s board of directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 04:08 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gilmartin Kathleen A

(Last) (First) (Middle)

1300 W SAM HOUSTON PKWY S

SUITE 300

(Street)

HOUSTON TEXAS 77042

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
U S PHYSICAL THERAPY INC /NV [ USPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		2,306	A	$61.61	27,092(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates.

	/s/ Kate Venturina, as attorney-in-fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)